Screener
Rhythm Pharmaceuticals, Inc. RYTM Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Long-term liabilities: | ||
| Deferred royalty obligation | 98,339 | 100,886 |
| Lease liability, non-current | 3,163 | 3,342 |
| Total liabilities | 204,700 | 210,170 |
| Commitments and contingencies (Note 14) | ||
| Series A convertible preferred stock, $0.001 par value: 150,000 shares authorized; 115,000 and 132,500 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Liquidation preference of $115,000 and $132,500 as of March 31, 2026, and December 31, 2025, respectively. | 114,710 | 130,957 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value: 9,850,000 shares authorized; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s total liabilities?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported total liabilities of $204.7M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s total liabilities decreased by 8.5% year-over-year, from $223.6M to $204.7M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s total liabilities has grown at a 59.2% compound annual growth rate (CAGR), from $20.55M to $210.17M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude